Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2012-04-04
Original SEC Filing: Click here

---

Webplus: BSPM/20120404/8-K/2_EX-3.1/000.htm SEC Original: ex3-1.htm
ARTICLES OF AMENDMENT TO THE ARTICLES OFORPORATION OF BIOSTAR PHARMACEUTICALS, This is to certify that: SECOND THIRD FOURTH IN WITNESS WHEREOF Biostar Pharmaceuticals, Ronghua Wang Shuang Gong Chief Executive Officer Secretary ex3-1.htm 2 EX-3.1

---

---

Webplus: BSPM/20120404/8-K/3_EX-99.1/000.htm SEC Original: ex99-1.htm
BIOSTAR PHARMACEUTICALS TO EFFECT REVERSE STOCKLIT — XIANYANG, China, April 3, 2012 a result of the reverse stocklit, the number of outstandingmmon shares will be reduced to approximately 9,398,892.Fractional stockholdings will be rounded up to the nearest whole number.The reverse stocklit will affectl stockholders uniformly and will not affect any stockholders ownership percentage of the

---

---

Webplus: BSPM/20120404/8-K/1/000.htm SEC Original: biostar8k040312.htm
FORM 8-K CURRENT REPORT April 3, 2012te of Report (Date of earliest event reported): BIOSTAR PHARMACEUTICALS, Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer oforporation) Identification No.) No. 588 Shiji Xi Avenue Xianyang City, Shaanxi Province Peoples Republic of China 712046 86-029-33686638 N/A (Former name or formerdress, if changed since last report)

---

Company Information:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2012-04-04CIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046